Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,781 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 450
Recruiting: 248
Ph III recruiting: 38
Growth YoY: +6.6%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 101–127 of 127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06599827	Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC(iMHRT-LARC)	not yet recruiting	Phase 2	54	Shanghai Zhongshan HospitalOTHER	1	Sep 19, 2024	clinicaltrials
NCT06567756	Conformal Sphincter-Preservation Operation Versus InterSphincteric Resection on Anal Function in Low Rectal Cancer	not yet recruiting	N/A	84	Changhai HospitalOTHER	0	Aug 23, 2024